Welcome, Guest. Please login or register.
July 18, 2024, 04:59:25 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 203
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 74
Total: 74


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Genetic Markers May Predict Liver Cancer  (Read 6564 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Genetic Markers May Predict Liver Cancer
« on: November 30, 2018, 11:11:39 am »
Scientists have found new genetic indicators associated with the development of hepatocellular carcinoma (HCC, the most common form of liver cancer) as well as worse outcomes among those with the disease. With more research, investigators could establish expression of the genes in question as biomarkers that could be used to help detect liver cancer early and provide more effective treatment.

“We know that 90 percent of all hepatocellular carcinoma cases start with liver cirrhosis,” study author Salvatore Papa, PhD, of the University of Leeds in the United Kingdom said in a press release. “So by pinpointing when cirrhosis progresses to cancer, we could improve early detection and treatment—with surgery, chemo and radiotherapy, but perhaps also with new treatments which reverse the transition.”

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.